Logo Medical XPRT
Companies
Products
Services
Software
Training
Applications
Sign in
List your business

Advertising options
  1. Home
  2. News
  3. intestinal bacteria
Show results for
Products
Services

Companies

News
Articles
Videos

Refine by
Date

  • Older

Intestinal Bacteria Articles & Analysis

9 news found

Creative Proteomics Metabolomics Expands Service Offering with the Launch of Gut Microbiota Metabolomics Solution

Creative Proteomics Metabolomics Expands Service Offering with the Launch of Gut Microbiota Metabolomics Solution

Gut flora refers to the microorganisms living in the human intestinal tract, such as Bifidobacteria, Lactobacilli, etc. Over 10 trillion parasitic bacteria are present within the human intestinal tract. These bacteria live on and within human beings, survive relying on the digestive system through various biochemical reactions, ...

ByCreative Proteomics


CD BioGlyco Introduces HMOs Separation Service for Glycobiology Study

CD BioGlyco Introduces HMOs Separation Service for Glycobiology Study

HMOs can stimulate the growth of intestinal probiotics (such as bifidobacteria), inhibit the growth of harmful bacteria, maintain intestinal microecological balance, promote immune development, prevent necrotizing enterocolitis, promote cognitive development, and play an important role in growth and development and the development of infants. ...

ByCD BioGlyco.


New Preclinical Research Published in Nature Highlights an Active Role by Microbiome-Derived Metabolites in Brain Function and Anxiety-like Behavior

New Preclinical Research Published in Nature Highlights an Active Role by Microbiome-Derived Metabolites in Brain Function and Anxiety-like Behavior

In the murine model, the researchers used engineered gut bacteria that either constitutively produce or do not produce 4EPS. The authors demonstrated that 4EPS can enter brain tissue, and that chronic exposure to 4EPS leads to arrest of oligodendrocyte maturation and corresponding region-specific changes in myelination. ...

ByAxial Therapeutics Inc.


Creative Enzymes Launches a Weight Control Formula to Improve Intestinal Health

Creative Enzymes Launches a Weight Control Formula to Improve Intestinal Health

Later studies on lean mice found that the proportion of beneficial bacteria in the intestinal flora was much higher than that of fat mice. ...

ByCreative Enzymes


Microbiotica`s Live Bacterial Therapeutic, MB097, in development to begin clinical trials in 2022 in immuno-oncology

Microbiotica`s Live Bacterial Therapeutic, MB097, in development to begin clinical trials in 2022 in immuno-oncology

However clinical translation of this ground-breaking discovery has been hampered by large inconsistencies between studies in the intestinal bacteria associated with anti-PD1 efficacy. The Microbiotica platform is unrivalled in the comprehensiveness and precision by which it can profile the microbiome of patients. ...

ByMicrobiotica Limited


Microbiotica’s Live Bacterial Therapeutic, MB097, in development to begin clinical trials in 2022 in immuno-oncology

Microbiotica’s Live Bacterial Therapeutic, MB097, in development to begin clinical trials in 2022 in immuno-oncology

However clinical translation of this ground-breaking discovery has been hampered by large inconsistencies between studies in the intestinal bacteria associated with anti-PD1 efficacy. The Microbiotica platform is unrivalled in the comprehensiveness and precision by which it can profile the microbiome of patients. ...

ByMicrobiotica Limited


New study:  Nine out of ten U.S. infants experience gut microbiome deficiency

New study: Nine out of ten U.S. infants experience gut microbiome deficiency

Perhaps more importantly, B. infantis is increasingly linked to the development of the infant immune system, protecting the infant intestinal tract from potentially dangerous bacteria as well as lower incidence of common childhood conditions like colic and diaper rash. Researchers also discovered that potentially dangerous bacteria comprised, on ...

ByEvolve BioSystems, Inc.


Nature communications. ATP released by intestinal bacteria limits…

Nature communications. ATP released by intestinal bacteria limits…

T cell dependent secretory IgA (SIgA) generated in the Peyer’s patches (PPs) of the small intestine shapes a broadly diverse microbiota that is crucial for host physiology. ...

ByMV BioTherapeutics SA


Discovery of an anti-inflammatory molecule produced by gut bacteria

The researchers also showed that MAM’s effect was due to its ability to reduce the levels of certain immune system compounds in the intestinal mucosa that cause inflammation. It therefore seems that the bacteria that live in our guts protect us using the same tools as medical professionals. ...

ByINRA - French National Institute of Agronomical Research

  • Previous
  • Next
Need help finding the right suppliers?Try XPRT Sourcing. Let the XPRTs do the work for you
Back to top
About Medical XPRT

Medical XPRT is a global marketplace with solutions and suppliers for the medical sector, with product catalogs, articles, industry events, publications & more.

Channels

Solutions

  • Medical Equipment & Supplies
  • Medical Software
  • Medical Training Courses
  • Medical Industry Services
  • Medical Product Applications

Latest

  • Medical Industry News
  • Medical Industry Events

Publications

  • Medical Industry Articles & Case Studies
  • Medical Industry Books and Publications
  • Medical Industry Journals and Magazines
  • Medical Industry Downloads
  • Medical Industry Videos

Companies

  • Medical Industry Suppliers & Manufacturers

  • FAQs
  • Company sitemap
  • Category sitemap
Medical XPRT is part of XPRT Media All Rights Reserved.
Terms
Privacy
  • Medical XPRT RSS List
Our sites:
Environmental XPRT
Agriculture XPRT
Energy XPRT
XPRT